Gastric Artery Embolization Pressure Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current gastric artery embolization methods face challenges in controlling flow and pressure, leading to non-targeted embolization and potential adverse events due to reflux of embolic agents into non-target vessels, which complicates the procedure and reduces efficacy.

Innovation Solution

A pressure modulating device, such as a microvalve filter or inflatable balloon catheter, is deployed to infuse embolizing agents into the fundus while preventing delivery to proximal and distal non-target vessels, utilizing unique flow and pressure dynamics to ensure targeted delivery through a modified Seldinger technique.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If embolic agent is infused into the left gastric artery to treat obesity, then therapeutic effect is achieved through reduced ghrelin and gastric motility, but embolic agent refluxes into non-target vessels causing adverse events

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidnon-target embolization
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

A pressure modulating device is introduced as an intermediary between the embolic agent and the vascular system. This device temporarily modifies pressure dynamics to direct embolic flow preferentially into non-target vessels during infusion, preventing reflux into target vessels while maintaining therapeutic effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the pressure parameter dynamically during the embolization procedure. By temporarily increasing pressure in the left gastric artery system during embolic agent infusion, the method directs flow away from non-target vessels and reduces reflux, thereby preventing non-target embolization while maintaining therapeutic efficacy

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If current embolization methods are used without pressure control, then procedure simplicity is maintained, but non-targeted embolization occurs reducing efficacy

Engineering Contradiction:
Improveprocedure simplicityVSAvoidembolization precision
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The pressure modulating device serves as a mediator that automates pressure control during embolization. This intermediary system manages the complexity of pressure regulation, allowing the procedure to maintain simplicity in execution while achieving precise embolization through automated pressure modulation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The pressure modulating device operates autonomously to regulate pressure during embolization. The system self-adjusts pressure parameters to optimize embolic agent delivery, eliminating the need for complex manual pressure control while maintaining high precision in embolization targeting

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS9889031B1Method of gastric artery embolization
Publication Date: 2018.02.13 TRISALUS LIFE SCIENCES INC
  • US9889031B1 patent drawing
  • US9889031B1 patent drawing
  • US9889031B1 patent drawing

AI summary

A method of bariatric embolization includes deploying an intravascular pressure modulating device at a target location, operating the pressure modulating device to reduce pressure within the fundus, and infusing an embolizing agent into the fundus. Use of the pressure modulating device prevents delivery of the embolizing agent into proximal and distal non-target vessels. The method takes advantage of unique flow and pressure dynamics of the arterial vessels in the stomach.